Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The rancho bernardo study

Journal of the American College of Cardiology

Volumn 59, Issue 12, 2012, Pages 1101-1109

  Daniels, Lori B ^b,c   Barrett Connor, Elizabeth ^c   Clopton, Paul ^a,b   Laughlin, Gail A ^c   Ix, Joachim H ^a,b,c   Maisel, Alan S ^b,c  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

biomarkers; cardiovascular disease; elderly; natriuretic peptides; risk factors

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COMMUNITY LIVING; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALIFORNIA; CARDIOVASCULAR DISEASES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDEPENDENT LIVING; KAPLAN-MEIER ESTIMATE; LIPOCALINS; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL REVASCULARIZATION; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 84858233542     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.11.046     Document Type: Article

References (28)

1. P. Devarajan NGAL in acute kidney injury: from serendipity to utility Am J Kidney Dis 52 2008 395 399
2. A. Friedl, S.P. Stoesz, P. Buckley, M.N. Gould Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues Cell type-specific pattern of expression Histochem J 31 1999 433 441 (Pubitemid 29369301)
3. D. Bolignano, V. Donato, A. Lacquaniti Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene Cancer Lett 288 2010 10 16
4. D.H. Goetz, M.A. Holmes, N. Borregaard, M.E. Bluhm, K.N. Raymond, R.K. Strong The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition Mol Cell 10 2002 1033 1043 (Pubitemid 36001971)
5. Z. Tong, X. Wu, D. Ovcharenko, J. Zhu, C.S. Chen, J.P. Kehrer Neutrophil gelatinase-associated lipocalin as a survival factor Biochem J 391 2005 441 448 (Pubitemid 41532443)
6. M.H. Roudkenar, R. Halabian, Z. Ghasemipour Neutrophil gelatinase-associated lipocalin acts as a protective factor against H(2)O(2) toxicity Arch Med Res 39 2008 560 566 (Pubitemid 352033610)
7. A.L. Hemdahl, A. Gabrielsen, C. Zhu Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction Arterioscler Thromb Vasc Biol 26 2006 136 142 (Pubitemid 43732240)
8. L. Yan, N. Borregaard, L. Kjeldsen, M.A. Moses The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL) Modulation of MMP-9 activity by NGAL J Biol Chem 276 2001 37258 37265
9. Z.S. Galis, J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 2002 251 262 (Pubitemid 34633925)
10. K. Damman, D.J. van Veldhuisen, G. Navis, A.A. Voors, H.L. Hillege Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure Eur J Heart Fail 10 2008 997 1000
11. B. Poniatowski, J. Malyszko, H. Bachorzewska-Gajewska, J.S. Malyszko, S. Dobrzycki Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease Kidney Blood Press Res 32 2009 77 80
12. K.M. Choi, J.S. Lee, E.J. Kim Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease Eur J Endocrinol 158 2008 203 207 (Pubitemid 351298537)
13. T. Zografos, A. Haliassos, S. Korovesis, E. Giazitzoglou, E. Voridis, D. Katritsis Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease Am J Cardiol 104 2009 917 920
14. A.M. Elneihoum, P. Falke, L. Axelsson, E. Lundberg, F. Lindgarde, K. Ohlsson Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases Stroke 27 1996 1734 1738 (Pubitemid 26332495)
15. I. Anwaar, A. Gottsater, K. Ohlsson, I. Mattiasson, F. Lindgarde Increasing levels of leukocyte-derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischemia Cerebrovasc Dis 8 1998 310 317 (Pubitemid 28491091)
16. D. Bolignano, G. Basile, P. Parisi, G. Coppolino, G. Nicocia, M. Buemi Increased plasma neutrophil gelatinase-associated lipocalin levels predict mortality in elderly patients with chronic heart failure Rejuvenation Res 12 2009 7 14
17. A. Yndestad, L. Landro, T. Ueland Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure Eur Heart J 30 2009 1229 1236
18. A.S. Maisel, C. Mueller, R. Fitzgerald Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial Eur J Heart Fail 13 2011 846 851
19. P. Falke, A.M. Elneihoum, K. Ohlsson Leukocyte activation: relation to cardiovascular mortality after cerebrovascular ischemia Cerebrovasc Dis 10 2000 97 101 (Pubitemid 30107503)
20. W.K. Kremers Concordance for Survival Time Data: Fixed and Time-Dependent Covariates and Possible Ties in Predictor and Time Technical Report Series #80 2007 Mayo Clinic Rochester, MN 1 17
21. S. May, D.W. Hosmer A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model Lifetime Data Anal 4 1998 109 120 (Pubitemid 128480552)
22. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 20712 (Pubitemid 351193639)
23. M.J. Pencina, R.B. D'Agostino Sr., E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
24. A.M. Elneihoum, P. Falke, B. Hedblad, F. Lindgarde, K. Ohlsson Leukocyte activation in atherosclerosis: correlation with risk factors Atherosclerosis 131 1997 79 84 (Pubitemid 27240100)
25. L.B. Daniels, A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368 (Pubitemid 50011582)
26. D. Bolignano, G. Coppolino, A. Lacquaniti, M. Buemi From kidney to cardiovascular diseases: NGAL as a biomarker beyond the confines of nephrology Eur J Clin Invest 40 2010 273 276
27. D.A. Morrow, J.A. de Lemos Benchmarks for the assessment of novel cardiovascular biomarkers Circulation 115 2007 949 952 (Pubitemid 46328287)
28. Triage NGAL [package insert] 2009 Inverness Medical San Diego, CA